In the long-interval vaccine group serological evidence for a breakthrough infection was detectable in anti-N antibodies in 65% (15/23), in anti-S1 antibodies in 78% (18/23), and for Omicron BA.5 neutralizing titers in 48% (11/23) of infected HCWs. The gene discussed is PSMD1; the disease is infection.